{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:31:43Z","timestamp":1791765103353,"version":"4.3.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ssph-journal.org"],"crossmark-restriction":true},"short-container-title":["Int J Public Health"],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Cannabis is the most commonly used illicit substance and has been associated with mental health issues. In this study, we examined trends in hospitalizations due to cannabis use.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Data were obtained from the Swiss Federal Statistics Office and comprised hospital main diagnoses, gender, age group and region of all psychiatric inpatient cases in Switzerland from 1998 to 2020. We performed trend analyses of annual case rates with cannabinoid-related diagnoses and compared them to trend analyses of alcohol-related and psychotic disorders.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Case rates of CRDs significantly increased in the observed time period. From all psychiatric main diagnoses, CRDs were overrepresented in the age groups of 15\u201324 and 25\u201344\u00a0years.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> We found a sharp increase in hospitalizations for CRD. Future studies should test whether changes in the upcoming cannabis regulation, which can facilitate the implementation of interventions to address mental health among users, impact future hospitalization rates of CRD.<\/jats:p>","DOI":"10.3389\/ijph.2022.1605554","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:56:44Z","timestamp":1671620204000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A Nationwide Study of Inpatient Case Rate Incidence of Cannabis-Related Diagnoses in Switzerland"],"prefix":"10.3389","volume":"67","author":[{"given":"Philippe","family":"Pfeifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Moggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/j.lanepe.2021.100227","article-title":"Public Health Monitoring of Cannabis use in Europe: Prevalence of use, Cannabis Potency, and Treatment Rates","volume":"10","author":"Manthey","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and Cannabis use Disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global Statistics on Alcohol, Tobacco and Illicit Drug use: 2017 Status Report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.20344\/amp.10093","article-title":"The Road towards the Responsible and Safe Legalization of Cannabis use in Portugal","volume":"31","author":"Baptista-Leite","year":"2018","journal-title":"Acta Med Port"},{"key":"B5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/00952990.2019.1569669","article-title":"Six Policy Lessons Relevant to Cannabis Legalization","volume":"45","author":"Shover","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(19)31789-1","article-title":"Public Health Implications of Legalising the Production and Sale of Cannabis for Medicinal and Recreational use","volume":"394","author":"Hall","year":"2019","journal-title":"Lancet"},{"key":"B7","unstructured":"Medikamenten und Illegalen Drogen Nach Geschlecht und Alter: Swiss Federal Statistical Office2022"},{"key":"B8","unstructured":"Swiss Monitoring System of Addiction and Noncommunicable Diseases: Bundesamt f\u00fcr Gesundheit2022"},{"key":"B9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJM198304213081604","article-title":"The Nontherapeutic use of Psychoactive Drugs. a Modern Epidemic","volume":"308","author":"Nicholi","year":"1983","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1192\/bjp.157.1.25","article-title":"Cannabis and Psychosis. is there Epidemiological Evidence for an Association?","volume":"157","author":"Thornicroft","year":"1990","journal-title":"Br J Psychiatry"},{"key":"B11","unstructured":"World Drug Report 20222022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/eurpub\/ckab207","article-title":"Incidence of Inpatient Cases with Mental Disorders due to use of Cannabinoids in Germany: a Nationwide Evaluation","volume":"32","author":"Gahr","year":"2022","journal-title":"Eur J Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.24095\/hpcdp.40.5\/6.06","article-title":"Psychotic Disorder and Cannabis use: Canadian Hospitalization Trends, 2006-2015","volume":"40","author":"Maloney-Hall","year":"2020","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"B14","unstructured":"Population 1950-20212022"},{"key":"B15","unstructured":"International Statistical Classification of Diseases and Related Health Problems 10th Revision 20192019"},{"key":"B16","unstructured":"Hospitalization Trends in Swiss Psychiatric Hospitals 20192019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","article-title":"Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine use: Findings from the who World Mental Health Surveys","volume":"5","author":"Degenhardt","year":"2008","journal-title":"Plos Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The Contribution of Cannabis use to Variation in the Incidence of Psychotic Disorder Across Europe (eu-gei): a Multicentre Case-Control Study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109582","DOI":"10.1016\/j.drugalcdep.2022.109582","article-title":"Identifying Risk-Thresholds for the Association Between Frequency of Cannabis use and Development of Cannabis use Disorder: a Systematic Review and Meta-Analysis","volume":"238","author":"Robinson","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"B20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of Cannabis use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: a Systematic Review and Meta-Analysis","volume":"76","author":"Gobbi","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0269881111405362","article-title":"Adolescent Exposure to Cannabis as a Risk Factor for Psychiatric Disorders","volume":"26","author":"Rubino","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drugalcdep.2012.10.015","article-title":"Gender Differences in Cannabis use Disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions","volume":"130","author":"Khan","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/00952990.2021.1946071","article-title":"A Systematic Review and Meta-Analysis of Sex Differences in Cannabis use Disorder Amongst People with Comorbid Mental Illness","volume":"47","author":"Kozak","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1455072520964612","article-title":"Women's Views on Barriers and Facilitators for Seeking Alcohol and Drug Treatment in Belgium","volume":"38","author":"Schamp","year":"2021","journal-title":"Nordisk Alkohol Nark"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/jamapsychiatry.2020.1035","article-title":"Association of High-Potency Cannabis use with Mental Health and Substance use in Adolescence","volume":"77","author":"Hines","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of Patients in South London with First-Episode Psychosis Attributable to use of High Potency Cannabis: A Case-Control Study","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","article-title":"Association between cannabis and psychosis: epidemiologic evidence","volume":"79","author":"Gage","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/jamapsychiatry.2018.0568","article-title":"Association of Substance use Disorders with Conversion from Schizotypal Disorder to Schizophrenia","volume":"75","author":"Hjorthoj","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamapsychiatry.2021.1471","article-title":"Development Over Time of the Population-Attributable Risk Fraction for Cannabis use Disorder in Schizophrenia in Denmark","volume":"78","author":"Hjorthoj","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B30","unstructured":"Hospitalisation Rate for Mental Disorders 20222021"}],"container-title":["International Journal of Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.ssph-journal.org\/articles\/10.3389\/ijph.2022.1605554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:56:47Z","timestamp":1671620207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ssph-journal.org\/articles\/10.3389\/ijph.2022.1605554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":30,"alternative-id":["10.3389\/ijph.2022.1605554"],"URL":"https:\/\/doi.org\/10.3389\/ijph.2022.1605554","relation":{},"ISSN":["1661-8564"],"issn-type":[{"value":"1661-8564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"article-number":"1605554"}}